Article Versions Notes

Devi GR, Finetti P, Morse MA, Lee S, de Nonneville A, Van Laere S, Troy J, Geradts J, McCall S, Bertucci F. Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. Cancers. 2021; 13(11):2807. https://doi.org/10.3390/cancers13112807

Devi, Gayathri R., Pascal Finetti, Michael A. Morse, Seayoung Lee, Alexandre de Nonneville, Steven Van Laere, Jesse Troy, Joseph Geradts, Shannon McCall, and Francois Bertucci. 2021. "Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy" Cancers 13, no. 11: 2807. https://doi.org/10.3390/cancers13112807

Devi, G. R., Finetti, P., Morse, M. A., Lee, S., de Nonneville, A., Van Laere, S., Troy, J., Geradts, J., McCall, S., & Bertucci, F. (2021). Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. Cancers, 13(11), 2807. https://doi.org/10.3390/cancers13112807